• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉减少症与癌症患者接受食管切除术的发病率、死亡率或复发率无关。

Sarcopenia is not associated with morbidity, mortality, or recurrence after esophagectomy for cancer.

机构信息

Oregon Health & Science University, Department of Surgery, 3181 SW Sam Jackson Park Rd, Mail Code L223, Portland, OR 97239, USA.

Oregon Health & Science University, Department of Diagnostic Radiology, 3181 SW Sam Jackson Park Road, Mail Code 340, Portland, OR 97239, USA.

出版信息

Am J Surg. 2018 May;215(5):813-817. doi: 10.1016/j.amjsurg.2017.12.017. Epub 2018 Jan 4.

DOI:10.1016/j.amjsurg.2017.12.017
PMID:29310892
Abstract

BACKGROUND

Sarcopenia is associated with increased morbidity and mortality in hepatic, pancreatic and colorectal cancer. We examined the effect of sarcopenia on morbidity, mortality, and recurrence after resection for esophageal cancer.

METHODS

Retrospective review of consecutive esophagectomies from 2010 to 2015. Computed tomography studies were analyzed for sarcopenia. Morbidity was analyzed using Fischer's test and survival data with Kaplan Meier curves.

RESULTS

The sarcopenic group (n = 127) had lower BMI, later stage disease, and higher incidence of neoadjuvant radiation than those without sarcopenia (n = 46). There were no differences in morbidity or mortality between the groups (p = .75 and p = .31, respectively). Mean length of stay was similar (p = .70). Disease free and overall survival were similar (p = .20 and p = .39, respectively).

CONCLUSION

There is no association between sarcopenia and increased morbidity, mortality and disease-free survival in patients undergoing esophagectomy for cancer. Sarcopenia in esophageal cancer may not portend worse outcomes that have been reported in other solid tumors.

摘要

背景

肌肉减少症与肝、胰和结直肠癌的发病率和死亡率增加有关。我们研究了肌肉减少症对食管癌切除术后发病率、死亡率和复发的影响。

方法

回顾性分析 2010 年至 2015 年连续进行的食管切除术。对计算机断层扫描研究进行了肌肉减少症分析。使用费舍尔检验分析发病率,使用 Kaplan-Meier 曲线分析生存数据。

结果

肌肉减少症组(n=127)的 BMI 较低,疾病分期较晚,且新辅助放疗的发生率高于无肌肉减少症组(n=46)。两组之间的发病率或死亡率无差异(p=0.75 和 p=0.31)。平均住院时间相似(p=0.70)。无病生存率和总生存率相似(p=0.20 和 p=0.39)。

结论

在接受食管癌切除术的患者中,肌肉减少症与发病率、死亡率和无病生存率增加之间没有关联。在其他实体瘤中报道的肌肉减少症与预后不良之间可能没有关联。

相似文献

1
Sarcopenia is not associated with morbidity, mortality, or recurrence after esophagectomy for cancer.肌肉减少症与癌症患者接受食管切除术的发病率、死亡率或复发率无关。
Am J Surg. 2018 May;215(5):813-817. doi: 10.1016/j.amjsurg.2017.12.017. Epub 2018 Jan 4.
2
Sarcopenia/Muscle Mass is not a Prognostic Factor for Short- and Long-Term Outcome After Esophagectomy for Cancer.肌肉减少症/肌肉量并非食管癌切除术后短期和长期预后的预后因素。
World J Surg. 2016 Nov;40(11):2698-2704. doi: 10.1007/s00268-016-3603-1.
3
Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer.肌肉减少症:在局部晚期食管癌的多模态管理中,其流行率及对手术和肿瘤学结局的影响。
Ann Surg. 2017 Nov;266(5):822-830. doi: 10.1097/SLA.0000000000002398.
4
Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.新辅助治疗后开放与微创Ivor Lewis食管癌切除术的疗效
Ann Thorac Surg. 2016 Mar;101(3):1097-103. doi: 10.1016/j.athoracsur.2015.09.062. Epub 2015 Dec 1.
5
Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis.术前肌少症是食管癌患者术后预后不良的预测因素:一项全面的系统回顾和荟萃分析。
Dis Esophagus. 2019 Mar 1;32(3). doi: 10.1093/dote/doy115.
6
A bridging stent to surgery in patients with esophageal and gastroesophageal junction cancer has a dramatic negative impact on patient survival: A retrospective cohort study through data acquired from a prospectively maintained national database.一项关于食管和胃食管交界癌患者手术桥接支架的回顾性队列研究:通过从一个前瞻性维护的国家数据库获取的数据进行分析,发现其对患者生存有显著负面影响。
Dis Esophagus. 2017 Feb 1;30(3):1-7. doi: 10.1111/dote.12474.
7
En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.对于食管腺癌新辅助治疗后,与经裂孔切除术相比,整块食管切除术可降低局部复发率并提高生存率。
J Thorac Cardiovasc Surg. 2008 Jun;135(6):1228-36. doi: 10.1016/j.jtcvs.2007.10.082. Epub 2008 May 23.
8
Discussion of "Sarcopenia is not associated with morbidity, mortality, or recurrence after esophagectomy for cancer".
Am J Surg. 2018 May;215(5):818. doi: 10.1016/j.amjsurg.2017.11.056. Epub 2018 Jan 31.
9
Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidity.新辅助放化疗后行杂交微创Ivor Lewis食管癌切除术可获得极佳的长期生存结果,且并发症极少。
J Surg Oncol. 2016 Dec;114(7):838-847. doi: 10.1002/jso.24409. Epub 2016 Aug 28.
10
Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma.食管鳞状细胞癌局部复发的危险因素及食管癌切除术的最佳长度
Ann Thorac Surg. 2016 Oct;102(4):1074-80. doi: 10.1016/j.athoracsur.2016.03.117. Epub 2016 Jun 11.

引用本文的文献

1
Sarcopenic psoas muscle surface area predicts short and long-term mortality for oesophageal cancer patients.肌少症性腰大肌表面积可预测食管癌患者的短期和长期死亡率。
J Thorac Dis. 2025 May 30;17(5):2926-2936. doi: 10.21037/jtd-24-1919. Epub 2025 May 28.
2
Sarcopenia and adverse surgical outcomes following cholecystectomy.胆囊切除术后的肌肉减少症与不良手术结局
J Anesth. 2025 May 16. doi: 10.1007/s00540-025-03512-y.
3
Effects of respiratory sarcopenia on the postoperative course in elderly lung cancer patient: a retrospective study.
呼吸肌少肌症对老年肺癌患者术后病程的影响:一项回顾性研究。
J Cardiothorac Surg. 2025 Jan 18;20(1):71. doi: 10.1186/s13019-024-03185-w.
4
Impact of nutrition risk index, prognostic nutritional index and skeletal muscle index on early myelosuppression of first-line chemotherapy in stage IV gastric cancer patients.营养风险指数、预后营养指数和骨骼肌指数对IV期胃癌患者一线化疗早期骨髓抑制的影响
BMC Gastroenterol. 2024 Dec 18;24(1):452. doi: 10.1186/s12876-024-03548-6.
5
Adverse postoperative outcomes in elderly patients with sarcopenia.老年肌少症患者术后不良结局。
BMC Geriatr. 2024 Jun 27;24(1):561. doi: 10.1186/s12877-024-05066-2.
6
Sarcopenia is a Poor Predictor of Outcomes in Elective Colectomy for Diverticulitis.肌少症是预测择期憩室炎结肠切除术结局不良的一个较差指标。
Am Surg. 2024 Jun;90(6):1309-1316. doi: 10.1177/00031348241229630. Epub 2024 Jan 24.
7
The impact of sarcopenia on esophagectomy for cancer: a systematic review and meta-analysis.肌肉减少症对癌症食管切除术的影响:系统评价和荟萃分析。
BMC Surg. 2023 Aug 17;23(1):240. doi: 10.1186/s12893-023-02149-6.
8
Prognostic Value of Sarcopenia and Metabolic Parameters of F-FDG-PET/CT in Patients with Advanced Gastroesophageal Cancer.肌少症及 F-FDG-PET/CT 代谢参数在晚期胃食管癌患者中的预后价值
Diagnostics (Basel). 2023 Feb 22;13(5):838. doi: 10.3390/diagnostics13050838.
9
Muscle loss 6 months after surgery predicts poor survival of patients with non-metastatic colorectal cancer.术后6个月的肌肉流失预示着非转移性结直肠癌患者的生存率较低。
Front Nutr. 2022 Dec 1;9:1047029. doi: 10.3389/fnut.2022.1047029. eCollection 2022.
10
The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta-analysis.肌肉减少症在食管癌中的预后价值:系统评价和荟萃分析。
J Cachexia Sarcopenia Muscle. 2023 Feb;14(1):3-16. doi: 10.1002/jcsm.13126. Epub 2022 Nov 22.